Bleeding News and Research

RSS

Gene therapy may help correct molecular flaws that cause brain disease

Neuroscientists have forged an unlikely molecular union as part of their fight against diseases of the brain and nervous system.

9 Jan 2010

New cardiac procedure may reduce complications and hospital costs

A new approach to common cardiac procedures called transradial angiography might lead to reduced patient complications and recovery time and decreased hospital costs.

7 Jan 2010

ProFibrix B.V. receives loan up to $7.4 million to develop its new hemostat Fibrocaps

ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced that SenterNovem, an agency of the Dutch Ministry of Economic Affairs, has granted the company a loan under its new Innovation Credit scheme of potentially up to EUR 5 million to finance the further clinical development of its unique new hemostat Fibrocaps(TM).

7 Jan 2010

CCAC doubles its efforts to convince Canadians to prevent colorectal cancer

Following the results of the Angus Reid Strategies and the Applied Health Research Centre at Toronto's St. Michael's Hospital survey conducted on behalf of the Canadian Partnership Against Cancer finding that the majority of Canadians have a good understanding of the benefits of colorectal cancer screening, but are not taking action to get screened, the Colorectal Cancer Association of Canada ("CCAC") is doubling its efforts in 2010 to convince Canadians that they must be more proactive concerning their health and the onset of colorectal cancer.

7 Jan 2010

IPMT procedure can benefit patients with acute deep vein thrombosis

Patients with acute deep vein thrombosis (DVT) develop potentially dangerous blood clots and can suffer severe leg pain and swelling. Doctors with Virginia Interventional & Vascular Associates (VIVA) report success over the past two years in treating acute DVT patients with a procedure called isolated pharmacomechanical thrombolysis (IPMT), which destroys clots much faster than traditional therapies.

7 Jan 2010

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

Results from a health economic substudy of the TRITON-TIMI 38 clinical trial showed that among patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI), including stenting, treatment with Effient(®) (prasugrel) compared with branded clopidogrel (Plavix(®)) was more cost effective, and in most cases cost saving.

6 Jan 2010

Montefiore Medical Center first to perform minimally invasive procedure on uterine fibroids

Montefiore Medical Center recently became the only hospital on the East Coast to conduct the Radio Frequency Ablation procedure to shrink uterine fibroids in women 30 years and older.

6 Jan 2010

University of Western Ontario receives grant to conduct randomized trial for Crohn's disease

Robarts Clinical Trials at The University of Western Ontario in London, Canada, has been awarded a 4.7 million dollar grant to conduct a randomized controlled trial evaluating treatment options for Crohn's disease.

5 Jan 2010

Boston Scientific commences enrollment in its TAXUS Liberte Stent System study

Boston Scientific Corporation today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study is designed to evaluate real-world clinical outcomes data for the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System in combination with a dual antiplatelet therapy drug regimen that includes aspirin and Effient®, a new antiplatelet medication. Co-sponsors of the study include Eli Lilly and Company and Daiichi Sankyo, Inc., manufacturers of Effient, which was recently approved by the U.S. Food and Drug Administration (FDA).

4 Jan 2010

Significant limitations in new Ginkgo biloba study published in JAMA, says ABC

New research findings published this week on a standardized Ginkgo biloba extract are very limited and the public should focus on the well-documented cognitive and cardiovascular benefits of ginkgo, said the American Botanical Council (ABC), an independent nonprofit research and education organization.

30 Dec 2009

CSL Behring awards four advocacy grants to patient organizations in the U.S.

CSL Behring, a global leader in the plasma-protein biotherapies industry and a subsidiary of CSL Limited, has awarded four advocacy grants totaling $87,000 to patient organizations in the United States through the Local Empowerment for Advocacy Development (LEAD) program.

29 Dec 2009

Steroids not superior to laser treatments for DME

Researchers led by specialists at the Johns Hopkins Wilmer Eye Institute have found that injecting a corticosteroid, triamcinolone, directly into the eye may slow the progression of proliferative diabetic retinopathy, a complication of diabetes that frequently leads to blindness.

27 Dec 2009

Combination of ropivacaine and fibrin sealant is effective in reducing pain after LC procedure

Fibrin sealant has been an extremely effective and widely used adjunct to surgical procedures to control diffuse slow bleeding over large surfaces. In addition, fibrin sealant has been used as a carrier for other compounds. Thus, it has been used to release medicines slowly at a fixed site and is therefore effective for a long time.

23 Dec 2009

Cervical cancer more common among poorer women than more affluent women, say scientists

One of the reasons why cervical cancer is more common among poorer women could be because they start having sex at a younger age than more affluent women, scientists have said.

23 Dec 2009

Facial plastic surgeon refines rhinoplasty with 3-D endoscopic high definition system

Sam Rizk, M.D., F.A.C.S. (www.drsamrizk.com), takes facial plastic surgery into the future by incorporating the same technology used for years in industrial design to enhance rhinoplasty techniques by empowering him to achieve precise surgical outcomes.

22 Dec 2009

Physicians' bedside exams superior to high-tech CT scan, study finds

Sometimes, a simple bedside exam performed by a skilled physician is superior to a high-tech CT scan, a Loyola University Health System study has found.

19 Dec 2009

GSK receives European CHMP positive opinion for Revolade

Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has received a positive opinion for Revolade® (eltrombopag/Promacta®) from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).

18 Dec 2009

NiTi Surgical Solutions' ColonRing used for the first time in a colorectal surgery in China

NiTi™ Surgical Solutions, an innovative surgical device company, today announced that its ColonRing™, the first major advance in closure for gastrointestinal surgery in more than 30 years, has been used for the first time in a colorectal surgery in China. The ColonRing anastomosis device was launched in the United States in May 2008 and has been successfully applied in thousands of patients.

18 Dec 2009

Pennsylvania's Patient Safety Advisory targets complications during pregnancy and childbirth

The complications of pregnancy and childbirth have been targeted in the Pennsylvania Patient Safety Authority's 2009 December Supplementary Patient Safety Advisory. The special issue provides gynecologists, obstetricians, midwives and the entire obstetric team, with strategies to help them prevent the complications based upon real Pennsylvania data.

17 Dec 2009

Synthetic platelets halt blood-clotting time

Blood loss is a major cause of death from roadside bombs to freeway crashes. Traumatic injury, the leading cause of death for people age 4 to 44, often overwhelms the body's natural blood-clotting process.

17 Dec 2009

Bleeding News and Research

Gene therapy may help correct molecular flaws that cause brain disease

New cardiac procedure may reduce complications and hospital costs

ProFibrix B.V. receives loan up to $7.4 million to develop its new hemostat Fibrocaps

CCAC doubles its efforts to convince Canadians to prevent colorectal cancer

IPMT procedure can benefit patients with acute deep vein thrombosis

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

Montefiore Medical Center first to perform minimally invasive procedure on uterine fibroids

University of Western Ontario receives grant to conduct randomized trial for Crohn's disease

Boston Scientific commences enrollment in its TAXUS Liberte Stent System study

Significant limitations in new Ginkgo biloba study published in JAMA, says ABC

CSL Behring awards four advocacy grants to patient organizations in the U.S.

Steroids not superior to laser treatments for DME

Combination of ropivacaine and fibrin sealant is effective in reducing pain after LC procedure

Cervical cancer more common among poorer women than more affluent women, say scientists

Facial plastic surgeon refines rhinoplasty with 3-D endoscopic high definition system

Physicians' bedside exams superior to high-tech CT scan, study finds

GSK receives European CHMP positive opinion for Revolade

NiTi Surgical Solutions' ColonRing used for the first time in a colorectal surgery in China

Pennsylvania's Patient Safety Advisory targets complications during pregnancy and childbirth

Synthetic platelets halt blood-clotting time

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News